KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Non-Current Assets (2016 - 2025)

Bausch Health Companies' Non-Current Assets history spans 17 years, with the latest figure at $20.2 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 2.6% year-over-year to $20.2 billion; the TTM value through Dec 2025 reached $82.2 billion, down 2.97%, while the annual FY2025 figure was $20.2 billion, 2.6% down from the prior year.
  • Non-Current Assets for Q4 2025 was $20.2 billion at Bausch Health Companies, down from $20.6 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $24.8 billion in Q1 2021 and bottomed at $20.2 billion in Q4 2025.
  • The 5-year median for Non-Current Assets is $21.4 billion (2022), against an average of $21.8 billion.
  • The largest annual shift saw Non-Current Assets skyrocketed 553.89% in 2021 before it fell 9.14% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $23.6 billion in 2021, then decreased by 9.14% to $21.4 billion in 2022, then grew by 1.47% to $21.8 billion in 2023, then fell by 4.62% to $20.7 billion in 2024, then decreased by 2.6% to $20.2 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Non-Current Assets are $20.2 billion (Q4 2025), $20.6 billion (Q3 2025), and $20.8 billion (Q2 2025).